About us

Preci-Health^TM is revolutionizing the landscape of medical care by providing accessible, safe and virtually painless
solutions for blood sampling and injections – anytime, anywhere. Our vision is to ensure every individual has the tools needed to manage their health
with unprecedented accuracy and ease – ultimately, leading to informed decision making and improved healthcare outcomes.

At the core of Preci-Health^TM‘s groundbreaking offerings is our flagship product, ezdraw^TM – a multi-tube blood sampler designed to shatter accessibility
constraints within the market. Capable of multi-tube extraction with a single, high-volume draw – ezdraw^TM is specifically compatible with standard
vacutainers to match existing workflows in laboratories and other healthcare settings. Supported by an AI-driven companion application with cutting-
edge facial recognition technology, ezdraw^TM also offers an unprecedented patient authentication process and real-time guidance for precision and
enhanced user experience. With ezdraw^TM, Preci-Health^TM not only provides a product, but also leads a revolution setting new accessibility, efficiency,
and accuracy guidelines for the blood collection industry.

Our dedication to democratizing healthcare extends beyond our suite of intuitive, patient-centric solutions. We are a team of experienced healthcare
and technology leaders, across multiple disciplines and with several decades of expertise – all who understand that sustained change must come from
building a new standard of care, together. Preci-Health^TM brings together individuals, healthcare providers, laboratories, and innovators to improve
access, collaborate and ultimately, usher in a healthier population. Join us on this transformative journey as we redefine healthcare together.

We are improving the health of the population,
one blood-draw at a time

Blood collection

Testing for, and management
of, illness relies on sufficient
blood sampling tools

Knowledge management

Health data gathered from
testing leads to early diagnosis
and cost reduction

Healthier population

Enhanced care delivery, monitoring
capabilities, and ongoing health management
resulting in improved population health

Board of Directors

Dr. Craig Cook

Chairman of the Board
& Medical Advisor

A medical doctor with an MBA from the London Business School, Dr. Cook brings more than 20 years of experience in the international pharma, biotech and medtech industries. Throughout the course of his career he held increasingly senior roles in drug development and commercialization at pharmaceutical companies such as Eli Lilly, Johnson & Johnson, Novartis and EMD Serono. Dr. Cook was CEO of Midatech Pharma PLC, a UK-based company focused on delivering innovative oncology and rare disease products to patients, and most recently CEO of Herantis Pharma PLC a Finnish company developing molecules for the treatment of neurodegenerative disease. Craig has worked in multiple therapeutic areas including central nervous system (CNS) and immunology. He is a qualified physician, has a BSc in Pharmacology, Diploma in Anaesthesiology, MBA from the London Business School, and Masters in Pharmaceutical Medicine from Kings College London.

Lucien Vouillamoz

CTO & Co-Founder
Board Member

Mr. Lucien Vouillamoz is an electronics and nuclear engineer. He is the inventor of the hydromechanical watch technology (HYT Watches), as well as co-founder of several successful high-tech startups. In 2010, he co-founded Preciflex SA and served as CEO & board member until 2012, and then as Chief Innovation Officer. While in this role, he invented the concept of Single Use Fixed Dose Micro Injection - the patents that underpin the creation of PreciHealth. He served as an IT consultant for the French automotive group PSA from 2016-2020. He chairs the GANYDAR Foundation, active in creating educational, professional and entrepreneurial opportunities for young, vulnerable Latin Americans.

Patrick Berdoz

Co-Founder
& Board Member

Patrick Berdoz has been a serial entrepreneur for more than 20 years in various innovative sectors (medtech, watch and real estate). He is the Co-founder and Chairman of HYT SA and Preciflex SA. Between 1994 and 2007, he was the CEO and Chairman of Precimed Group which grew from 17 employees to 700. In 1998, he established Precimed in the USA, Japan and then China. He led the successful trade sale of Precimed Group to a publicly traded company in the US. He began his career at 28 as CEO and owner of Viso Medical, an intravenous therapy Company (Neuchâtel, Switzerland) that he sold at age 34 to a French Pharma. Patrick Berdoz is an economist from HEG in Lausanne, Switzerland

Michel Orsinger

Michel Orsinger is a true global leader with a proven track record of over 30 years in leading companies in the consumer and healthcare industries. Today, he is an investor and holds various board member positions in start-ups, in a PE portfolio company (Lima) and in a larger pharmaceutical company (Takeda). He is also an advisor in the Private Equity company EQT. From 2012 to 2015, Michel was the Chairman of Global Orthopedics at Johnson & Johnson. He was also a member of Johnson & Johnson’s global management team. Michel established the largest and most comprehensive orthopedic company in the world by merging Synthes with J&J’s orthopedic business DePuy, generating $10 billion revenue with 23,000 employees. Prior to joining Synthes, Michel spent 11 years with Sandoz and Novartis. He began his career with Procter & Gamble and Mars.

Harald J. Wester

Mr. Harald Wester has over 30 years of experience in innovation, development and production at Ferrari, Maserati, Audi, VW, Fiat and Stellantis. He is the Executive Chairman of Maserati and Chief Engineering Officer of Stellantis Group. He has been an active investor in life science and holds a master in mechanical engineering from the Technical University of Braunschweig in Germany.

Management Team

Shy Zymann

Chief Executive Officer

Shy brings over 25 years of experience in Management, Business Development, Sales and Marketing for high-tech companies, last 12 years in Medical Devices. Former CEO of 3 start-up companies and a co-founder of a leading Business Development company which assisted dozens of companies in market entry including leaders as IAI, Motorola Israel, Orbit and others. Shy has a proven track record of developing exponential revenue growth for companies, building GTM strategies and global distribution systems. Shy studied Computer and Physics at the Technion Institute, Business Administration at the College of Management (TLV) and MBA at the Wales University. Ret. Lieutenant Commander from the Israeli Navy.

Laurence Blazianu

Chief Business Officer

Laurence Blazianu worked in large and small size pharma-medtech-Dx-I-health companies (Roche, Kenta, Softhale) and at investment banks (Cukierman&Co LifeSciences, CreditSuisse), with a long-time experience supporting executive mission leading to value creation to investors /industry and market visibility. With 23 years of experience, Laurence in raising funds, attracting and managing partners, installing and improving the finance function, corporate reporting and closing of transactions. She started her carreer in strategic marketing and corporate analytics & strategy and sales at Roche UK, Roche US, Roche HQ before moving to finance industry.

Alain Jaccard, MSc, PMP

Chief Innovation Officer

Alain Jaccard is an innovation expert with a Masters in Science, Microengineering and Production technologies from EPFL, and a Project Management Professional (PMP®). Alain has gathered 25+ years of professional experience leading innovative projects within large international groups in home appliances, as well as in SMEs in automotive and machines industry, and horology; he also worked a few years in an emergency relief NGO. He has led Preciflex’s Operations since 2012 and has functioned as Chief Innovation Manager since 2017. Alain is an inventor in 27+ patent families, a significant portion of which are related to PreciHealth’s technology. Furthermore, he has managed PreciHealth’s Intellectual Property portfolio since the inception of the company.

Dr. Ron Gill

Chief Technology Officer

Dr. Ron Gill, PhD, is a seasoned R&D Manager with a passion for driving innovation in bioanalytical assays and related devices. With over 20 years of experience advancing research in academia, large industry, and start-up environments, he has notably served as CTO at both Xsensio SA and Biovolt BV. Ron holds a PhD in Chemistry from the Hebrew University of Jerusalem and dual degrees in Physics and Materials Science and Engineering—both awarded summa cum laude—from the Technion – Israel Institute of Technology.

Tomer Gershtein

Chief Operating Officer

With 17 years of expertise in SME operations management, Tomer Gershtein brings extensive knowledge in overseeing the production and operations of high-volume facilities. His experience includes successfully building and scaling up capacities to meet evolving demands. Tomer holds an EMBA with a specialization in Sustainable Business from BSL/Uni. St. Gallen, complemented by a B.Sc. in Architecture from Cardiff University (Wales).

Daniel Nesta

Chief Financial Officer

CFO with 25 years of experience in corporate financial strategy, including acquisitions, restructurings, scaling businesses, and participating in fundraising campaigns. Skilled in optimizing capital structures and driving sustainable development across various industries, such as biotechnology, watchmaking, and electronic monitoring systems. Holds a degree in Business Administration from the University of Applied Sciences and Arts of Western Switzerland in Neuchâtel and recently specialized in Corporate Tax (CAS) at the University of Neuchâtel.

Philippe Margairaz

Philippe Margairaz has been the project manager for PreciHealth’s medical device development since 2017. In addition to his PreciHealth responsibility, Philippe works as Head of Product Management at Preciflex. Before joining Preciflex, Philippe worked at Codman, a Johnson & Johnson company, for 14 years both in Switzerland and at its headquarter in the Boston area. He started as an engineer in the team responsible for the development and manufacture of a programmable implantable pump and was then the project manager for several internal development of devices. Philippe hold a master of mircroengineering from EPF, Lausanne and is PMP certified.

Helmut Lasser

Head of Digital Development

Helmut brings 20 years of experience in the mobile industry, former CTO of OnEmotion AG and Goldbach Mobile AG. Specialist in the software development, he applies his expertise in delivering innovative mobile solutions to a very wide range of sectors, covering the automotive industry to the pharmaceutical industry. Helmut have been one of the seed angel investors in the company.

Sanne van Delft

Clinical Manager

Dr. Sanne van Delft has a PhD in cell biology. In her thesis she studied the role of the protein Eps15 in the endocytosis of the EGF receptor and in the following years at the Dutch Cancer Institute (NKI) she worked on the activity of the small G-protein Rac. In 1999 she moved from laboratory research to clinical research at GlaxoSmithKline where she conducted various clinical trials. With 10 years' experience she left GSK for the diagnostic world. Starting as head of the clinical chemistry lab at Saltro Diagnostic Centre, which was followed by leading the Innovation team. When Saltro was taken over by Unilabs, the Innovation team became the International Innovation team for Unilabs. One of the major projects of this team was 'self-sampling of blood’. In 2022 she decided to start her own business, Delphi Solutions, working as a programme manager in all kinds of health projects. In December 2022 she started as Clinical Manager at PreciHealth.

Philippine Berdoz

BD Manager & US Rep

Philippine Berdoz has been involved with startups for the past 10 years. Philippine's journey commenced with a global marketing role in the orthopedic industry. In this capacity, she gained invaluable insights into the complexities of a highly regulated field with a focus on market analysis and strategy development. Philippine eventually pivoted to B2B SaaS startups where she spent most of her career scaling young innovative tech companies into market leaders and into new territories. In February 2023, Philippine enlisted as a member of the Preci-Health team with the objective of mobilizing resources and facilitating the deployment of the solution within the United States.

Anna Meletiou

Anna holds a PhD in Biophysics from the University of Exeter and a MSc in Biophysics and Molecular Life Sciences from the University of Bristol. She moved to the University of Bern to conduct cutting-edge research funded by the Swiss National Science Foundation (SNSF), focusing on cardiac calcium signaling. To complement her academic expertise, Anna completed the CAS CARAQA program, acquiring specialized competencies in Regulatory Affairs, Clinical Affairs and Quality Assurance tailored to the MedTech industry.
Currently, Anna is part of the Quality and Regulatory Department, where she ensures compliance with international regulations, maintains an active Quality Management System, and supports the launch of ezdraw in both EU and US markets.